A phase 3 trial of Cogent Biosciences’ bezuclastinib has hit its primary endpoint, teeing the biotech up to seek FDA approval ...

Add-on therapy and substitution monotherapy are both effective second-line treatments for women with idiopathic generalized epilepsy.

Background and objective Prior studies have suggested that patients with premature ventricular complexes (PVCs) may have an ...

Counties designated as maternity care deserts face significantly higher maternal mortality rates than those with full access ...

Before blaming your campaign, check your tracking. These seven conversion pitfalls in Google Ads can quietly wreck your ...

Industry Dynamics: According to SMM data, the PMI for the secondary aluminum industry in June rose slightly to 45.0% MoM from May, but still remained below the 50 mark, indicating that the industry ...

Atai and Beckley report that a single dose of BPL-003 reduced depression symptoms significantly and safely in ...

By adopting FDA-endorsed primary endpoints that are easier to achieve, Dimerix has bolstered the chances of its phase III ...

To avoid handing over sensitive data, some security experts are recommending a simple solution: travel with a burner phone.

They were randomised in a 2:1 ratio to receive either mifepristone (300–900 mg daily) or placebo for 24 weeks. Randomisation ...

Buying too early or too late could hit your wallet, as well as running the risk that your child outgrows what you bought. One ...